CHARMD
Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database
English (en)
Français (fr)
Español (es)
CNR Website
Home
Login
Data
All data
Antivirals
Bibliography
Therapeutic targets
Tools
Search
Submit mutations
Request expertise
Genotyping tool
Gene maps
Contact
Notice
How to cite
Last update : Mon 20 Apr 2026
TOP
Van Wechel LC
References:
Rank: 3 -
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens.(Nov 2007)
Filter:
Mutant
Gene
Virus
Reference
Mutations:
T813S
UL54
Human betaherpesvirus 5
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens. (Nov 2007)
T813S
UL54
Human betaherpesvirus 5
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens. (Nov 2007)
T813S
UL54
Human betaherpesvirus 5
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens. (Nov 2007)
G841A
UL54
Human betaherpesvirus 5
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens. (Nov 2007)
G841A
UL54
Human betaherpesvirus 5
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens. (Nov 2007)
G841A
UL54
Human betaherpesvirus 5
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens. (Nov 2007)
Tilloy
et al.
, 2024
Interdeposit Digital Number: IDDN.FR.001.420004.000.S.X.2024.000.31230
